Successful Treatment of Severe Tuberculosis With Contezolid Add‐On Regimen in a Patient Complicated With Acute Thrombocytopenia: A Case Report

Abstract

ABSTRACT Polypharmacy in managing severe tuberculosis patients usually poses a risk of adverse drug reactions. Contezolid is a new oxazolidinone antibiotic showing good in vitro and in vivo activity against Mycobacterium tuberculosis. Contezolid add‐on regimen shows promising efficacy and safety results in managing severe tuberculosis patients complicated with acute thrombocytopenia.

Keywords

• contezolid
• Mycobacterium tuberculosis
• thrombocytopenia
• treatment outcome
• tuberculosis